Search Results 41-50 of 16885 for Humira

  1. Rilonacept (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Do not take adalimumab (Humira®), anakinra (Kineret®), etanercept (Enbrel®), or infliximab (Remicade®) while you are being treated with this medicine ...

  2. Rheumatoid Arthritis Clinical Trials

    The purpose of this study is to evaluate the long-term safety and efficacy of CNTO 136 (sirukumab) in participants with rheumatoid arthritis (RA) who are ...

  3. Sarilumab (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Sarilumab injection is used alone or together with other medicines to treat symptoms of moderate to severe rheumatoid arthritis who have been treated with other ...

  4. A Study to Evaluate the Safety and Effectiveness of PF-06650833, PF-06700841, and PF 06826647 in Adults With Hidradenitis Suppurativa Evaluating the Safety and Effectiveness of PF-06650833, PF-06700841, and PF-06826647 in Adults with Moderate-to-Severe Hidradenitis Suppurativa - Mayo Clinic

    adalimumab (Humira®): 6 weeks;; infliximab (Remicade®), golimumab (Simponi®): 10 weeks;; certolizumab pegol (Cimzia®): 12 weeks. Participant must agree to ...

  5. Inflammatory Bowel Disease Clinical Trials - Mayo Clinic Research

    A Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients with Moderately to Severely Active Crohn's Disease Rochester ...

  6. Crohn's Disease Clinical Trials - Mayo Clinic Research

    A Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients with Moderately to Severely Active Crohn's Disease Rochester ...

  7. Psoriasis - Diagnosis and treatment - Mayo Clinic

    Options include etanercept (Enbrel), infliximab (Remicade), adalimumab (Humira), ustekinumab (Stelara), risankizumab-rzaa (Skyrizi), ixekizumab (Taltz), ...

  8. Consumer health Medications - Mayo Clinic

    Meditation. Yoga. Massage. Acupuncture. Use of supplements, such as vitamins, herbs and minerals. Music therapy. Integrative medicine aims to fit each person's ...

  9. Crohn's Disease Clinical Trials - Mayo Clinic Research

    A Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients with Moderately to Severely Active Crohn's Disease Rochester ...

  10. Expanded Access to Cyclic Irrigation in Patients Undergoing Exchange Arthroplasty - Mayo Clinic

    ... (Humira) Tocilizumab (Actemra) Etanercept (Enbrel) Anakinra (Kineret) Golimumab (Simponi) Secukinumab (Cosentyx) Infliximab (Remicade) Ustekinumab (Stelara) ...